Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

Direct Meds vs Invigor Medical

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.

Grade B− · #27

Direct Meds

One of the rare programs offering an oral/sublingual route on both molecules with all-inclusive pricing — but the verdict marks it down hard because the numbers are company-stated, not independently verified.

Visit Direct Meds
vs
WinnerGrade B+ · #6

Invigor Medical

An established telehealth pharmacy with a broad metabolic and hormone catalog.

Visit Invigor Medical

The verdict

Winner: Invigor Medical

Invigor Medical takes it with a higher Verdict Score — 88/100 to 82/100 (grade B+ vs B−). Patients who want GLP-1 care alongside a wider wellness/hormone program. Direct Meds still earns its place — needle-averse patients who specifically want a sublingual GLP-1 option and are willing to vet a newer operator themselves.

Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

80Real-world results88
82Price honesty87
80Prescriber access84
88Formulary choice86
82Cancellation fairness89
80Member support90

Price, coverage & features

MetricDirect MedsInvigor Medical
Verdict Score82/10088/100
GradeB−B+
Semaglutide$179/mo$199/mo
Tirzepatide$224/mo$339/mo
CoverageNot publicly listedNot disclosed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesNo

Direct Meds

What we like

  • Rare oral/sublingual drops on both molecules — sublingual semaglutide from $179/mo and tirzepatide from $224/mo — plus an injectable path
  • All-inclusive pricing with no separate membership fee to layer on top
  • Covers both semaglutide and tirzepatide rather than a single molecule

The caveats

  • Every option is compounded, not FDA-approved
  • Pricing is company-stated (from a press release) and not independently verified — treat the figures as claims, not confirmed rates
  • Newer entity (est. 2024) operating across several similar-looking domains, so confirm you're on the right one
  • States served are not disclosed, so coverage can't be verified before you sign up

Invigor Medical

What we like

  • Mid-market pricing on both molecules
  • Long-running operator with a broad catalog

The caveats

  • Does not publish an explicit states-served list
  • Compounded only

Also worth a look

Needle-averse patients who specifically want a sublingual GLP-1 option and are willing to vet a newer operator themselves.

Visit Direct Meds Read the full Direct Meds review →

Our pick — visit

Patients who want GLP-1 care alongside a wider wellness/hormone program.

Visit Invigor Medical Read the full Invigor Medical review →

Keep comparing

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.